"Hyperlipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions with excess LIPIDS in the blood.
Descriptor ID |
D006949
|
MeSH Number(s) |
C18.452.584.500.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperlipidemias".
Below are MeSH descriptors whose meaning is more specific than "Hyperlipidemias".
This graph shows the total number of publications written about "Hyperlipidemias" by people in this website by year, and whether "Hyperlipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1998 | 2 | 1 | 3 |
2001 | 2 | 0 | 2 |
2002 | 0 | 1 | 1 |
2003 | 2 | 2 | 4 |
2004 | 2 | 3 | 5 |
2005 | 5 | 2 | 7 |
2006 | 2 | 1 | 3 |
2007 | 1 | 1 | 2 |
2008 | 0 | 3 | 3 |
2009 | 2 | 0 | 2 |
2010 | 1 | 2 | 3 |
2011 | 1 | 0 | 1 |
2012 | 1 | 2 | 3 |
2013 | 2 | 2 | 4 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 2 | 1 | 3 |
2017 | 3 | 1 | 4 |
2018 | 0 | 2 | 2 |
2020 | 0 | 2 | 2 |
2021 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperlipidemias" by people in Profiles.
-
Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis. PLoS One. 2022; 17(11):e0277251.
-
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels. JAMA Netw Open. 2021 10 01; 4(10):e2128817.
-
Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES). Gynecol Oncol. 2020 07; 158(1):123-129.
-
Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
-
Evolocumab: Considerations for the Management of Hyperlipidemia. Curr Atheroscler Rep. 2018 03 06; 20(4):17.
-
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 01; 24(1):91-120.
-
Should an LDL-Cholesterol Target-Based Approach Be Readopted? Ann Pharmacother. 2018 02; 52(2):175-184.
-
Variations in biocorona formation related to defects in the structure of single walled carbon nanotubes and the hyperlipidemic disease state. Sci Rep. 2017 08 16; 7(1):8382.
-
Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group. Dig Dis Sci. 2017 08; 62(8):2133-2140.
-
Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential. Curr Atheroscler Rep. 2017 Mar; 19(3):12.